18-54224122-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The ENST00000256429.8(MBD2):āc.438C>Gā(p.Ser146Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000154 in 1,561,550 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000066 ( 0 hom., cov: 31)
Exomes š: 0.000016 ( 0 hom. )
Consequence
MBD2
ENST00000256429.8 missense
ENST00000256429.8 missense
Scores
3
4
12
Clinical Significance
Conservation
PhyloP100: 1.35
Genes affected
MBD2 (HGNC:6917): (methyl-CpG binding domain protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. The protein encoded by this gene may function as a mediator of the biological consequences of the methylation signal. It is also reported that the this protein functions as a demethylase to activate transcription, as DNA methylation causes gene silencing. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.3270716).
BS2
High AC in GnomAdExome4 at 23 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MBD2 | NM_003927.5 | c.438C>G | p.Ser146Arg | missense_variant | 1/7 | ENST00000256429.8 | NP_003918.1 | |
MBD2 | NM_015832.6 | c.438C>G | p.Ser146Arg | missense_variant | 1/3 | NP_056647.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MBD2 | ENST00000256429.8 | c.438C>G | p.Ser146Arg | missense_variant | 1/7 | 1 | NM_003927.5 | ENSP00000256429 | P1 | |
MBD2 | ENST00000583046.1 | c.438C>G | p.Ser146Arg | missense_variant | 1/3 | 1 | ENSP00000464554 | |||
MBD2 | ENST00000398398.6 | c.438C>G | p.Ser146Arg | missense_variant | 1/3 | 2 | ENSP00000381435 |
Frequencies
GnomAD3 genomes AF: 0.00000663 AC: 1AN: 150904Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
1
AN:
150904
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000102 AC: 2AN: 196414Hom.: 0 AF XY: 0.00000915 AC XY: 1AN XY: 109290
GnomAD3 exomes
AF:
AC:
2
AN:
196414
Hom.:
AF XY:
AC XY:
1
AN XY:
109290
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000163 AC: 23AN: 1410646Hom.: 0 Cov.: 35 AF XY: 0.0000171 AC XY: 12AN XY: 701938
GnomAD4 exome
AF:
AC:
23
AN:
1410646
Hom.:
Cov.:
35
AF XY:
AC XY:
12
AN XY:
701938
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000663 AC: 1AN: 150904Hom.: 0 Cov.: 31 AF XY: 0.0000136 AC XY: 1AN XY: 73666
GnomAD4 genome
AF:
AC:
1
AN:
150904
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
73666
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 29, 2023 | The c.438C>G (p.S146R) alteration is located in exon 1 (coding exon 1) of the MBD2 gene. This alteration results from a C to G substitution at nucleotide position 438, causing the serine (S) at amino acid position 146 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
T;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;T;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
N;.;N
MutationTaster
Benign
N;N;N
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;.
REVEL
Uncertain
Sift
Benign
T;T;.
Sift4G
Benign
T;T;D
Polyphen
B;.;D
Vest4
MutPred
Loss of glycosylation at S146 (P = 0.0102);Loss of glycosylation at S146 (P = 0.0102);Loss of glycosylation at S146 (P = 0.0102);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at